Syndicate

Latest KFF Health News Stories

Timeline: The Orphan Drug Act

KFF Health News Original

Follow the twists and turns of the orphan drug industry over the past three decades.

Interactive: How Orphan Drugs Win The ‘Monopoly’ Game

KFF Health News Original

Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.

Insurance Customers In Pennsylvania Look To Trump To Ease Their Burden

KFF Health News Original

Two Pennsylvania voters who buy health insurance on healthcare.gov are frustrated with how expensive the plans have become. They voted for Trump in hopes he can bring down health insurance costs.

As Obamacare Repeal Heats Up, Newly Insured North Carolinians Fret

KFF Health News Original

More than half a million people in North Carolina buy health insurance on healthcare.gov. Many are confused what will happen to their coverage as Republicans work to repeal the Affordable Care Act, but they still are signing up for 2017 plans.

Health Claims On The Rise For Kids With Type 2 Diabetes, Obesity-Related Conditions

KFF Health News Original

An analysis of claims data from 60 health insurers found a significant increase in the amount of treatments sought by young people for conditions traditionally associated with older people, such as high blood pressure and sleep apnea.

Seis cosas sorprendentes que podrían desaparecer junto con el Obamacare

KFF Health News Original

La Ley de Cuidado de salud Asequible afectó las primas y la cobertura de condiciones preexistentes. Pero el texto de más de 2.000 páginas contiene provisiones que afectan a diario a los estadounidenses.

Even In Trump Country, Rural Hospitals Brace For Damage From Health Law’s Repeal

KFF Health News Original

The Affordable Care Act, which President-elect Donald Trump has vowed to repeal, threw a number of life-savers to rural hospitals, which are vital but financially troubled centers. And its full repeal, without a comparable and viable replacement, could signal their death knell.